We are live on ! Find out more
ZAM

Zeal Asset Management Portfolio holdings

AUM $39.4M
1-Year Est. Return 38.83%
This Fund
S&P 500
This Quarter Est. Return
-11.94%
1 Year Est. Return
+38.83%
3 Year Est. Return
-26.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.4M
AUM Growth
-$19.1M
Cap. Flow
-$17.8M
Cap. Flow %
-60.58%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.7M
2
TSM icon
TSMC
TSM
+$33.5K

Top Sells

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$8.58M
2
HCM icon
HUTCHMED
HCM
+$5.08M
3
ZLAB icon
Zai Lab
ZLAB
+$2.71M
4
BEKE icon
KE Holdings
BEKE
+$2.12M
5
NBP
NovaBridge Biosciences American Depositary Shares
NBP
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 91.58%
2 Technology 8.42%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$36.7B
$18.9M 64.5%
139,904
-49,943
-26% -$8.58M
ZLAB icon
2
Zai Lab
ZLAB
$2.36B
$7.96M 27.09%
224,859
-63,349
-22% -$2.71M
MSFT icon
3
Microsoft
MSFT
$3.71T
$2.44M 8.32%
+10,238
New +$2.7M
TSM icon
4
TSMC
TSM
$2.17T
$28K 0.1%
+405
New +$33.5K
BEKE icon
5
KE Holdings
BEKE
$18.7B
– –
-119,751
Closed -$2.12M
HCM icon
6
HUTCHMED
HCM
$2.06B
– –
-421,140
Closed -$5.08M
NBP
7
NovaBridge Biosciences American Depositary Shares
NBP
$197M
– –
-194,538
Closed -$2.06M

Similar funds

BGDR
BC Gestao de Recursos Sao Paulo, Brazil $38.2M AUM
HCM
Hawkeye Capital Management Miami Beach, Florida $40.6M AUM 11.3% 1-Year Est. Return
BEVI
Braemar Energy Ventures III New York $37.9M AUM 66.45% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
NLG
New Legacy Group New York $36.6M AUM 36.77% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
SIP
Scott Investment Partners Henley-On-Thames, United Kingdom $43.5M AUM 17.97% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return

Zeal Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Zeal Asset Management held 7 positions worth $29.4M, down 39% from $48.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Zeal Asset Management withdrew a net $17.8M in Q3 2022, closing 3 positions and reducing 2 holdings. Its most notable exit was HUTCHMED, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 96% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Zeal Asset Management opened a new position in Microsoft worth $2.44M.

  • Zeal Asset Management's largest Q3 2022 buy was Microsoft: 10,238 shares worth $2.44M.
  • Zeal Asset Management's biggest Q3 2022 reduction was BeOne Medicines Ltd, cutting an estimated $8.58M.
  • Zeal Asset Management fully exited HUTCHMED in Q3 2022, selling an estimated $5.08M.
  • Zeal Asset Management's ten largest holdings make up 100% of its $29.4M portfolio in Q3 2022.
  • Zeal Asset Management opened 2 new positions and closed 3 in Q3 2022.
  • Zeal Asset Management's portfolio value fell 39% quarter-over-quarter to $29.4M.

Based on Zeal Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.